Engineered Nanoparticles for Drug Delivery in Cancer Therapy
The DOI matches its Crossref record; 579 of the 579 references it cites were found in a registry or an index.
Abstract
In medicine, nanotechnology has sparked a rapidly growing interest as it promises to solve a number of issues associated with conventional therapeutic agents, including their poor water solubility (at least, for most anticancer drugs), lack of targeting capability, nonspecific distribution, systemic toxicity, and low therapeutic index. Over the past several decades, remarkable progress has been made in the development and application of engineered nanoparticles to treat cancer more effectively. For example, therapeutic agents have been integrated with nanoparticles engineered with optimal sizes, shapes, and surface properties to increase their solubility, prolong their circulation half‐life, improve their biodistribution, and reduce their immunogenicity. Nanoparticles and their payloads have also been favorably delivered into tumors by taking advantage of the pathophysiological conditions, such as the enhanced permeability and retention effect, and the spatial variations in the pH value. Additionally, targeting ligands (e.g., small organic molecules, peptides, antibodies, and nucleic acids) have been added to the surface of nanoparticles to specifically target cancerous cells through selective binding to the receptors overexpressed on their surface. Furthermore, it has been demonstrated that multiple types of therapeutic drugs and/or diagnostic agents (e.g., contrast agents) could be delivered through the same carrier to enable combination therapy with a potential to overcome multidrug resistance, and real‐time readout on the treatment efficacy. It is anticipated that precisely engineered nanoparticles will emerge as the next‐generation platform for cancer therapy and many other biomedical applications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [103]
In the citing paper
“Vasculature plays an essential role in the growth and metastasis of malignant tumors [103].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [103]
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [103]
Citations
Cites
Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism
Kresge, C. T., Leonowicz, M. E., Roth, W. J., Vartuli, J. C., & Beck, J. S. (1992) · Nature · doi:10.1038/359710a0 · Cited by 16,275
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Chemistry and Properties of Nanocrystals of Different Shapes
Burda, C., Chen, X., Narayanan, R., & El-Sayed, M. A. (2005) · Chemical Reviews · doi:10.1021/cr030063a · Cited by 7,230
Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816
Research works printed but not linked: 29
- Aruna U., 2013, Inter. J. Inn. Pharm. Res., 4, 318
- Langer R., 1998, Nature, 392, 5
- Petre C. E., 2007, Int. J. Nanomed., 2, 277
- Lao J., 2013, J. Drug Delivery, 456409
- Saif M. W., 2007, JOP, 8, 166
- Matsumura Y., 1986, Cancer Res., 46, 6387
- Xu G., 2001, Clin. Cancer Res., 7, 3314
- 10.1016/j.addr.2012.09.008 · doi:10.1016/j.addr.2012.09.008 · Paper page
- Pundir S., 2013, Int. J. Drug Res. Technol., 3, 12
- 10.1021/jp077468 · doi:10.1021/jp077468
- Mohanraj V. J., 2006, J. Pharm. Res., 5, 561
- Ma Y. D., 2011, Int. J. Nanomed., 6, 2679
- 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F · doi:10.1002/(sici)1097-4636(199908)46:2<236::aid-jbm13>3.0.co;2-f
- Krishna R., 2000, Eur. J. Cancer Sci., 11, 265
- Kettiger H., 2013, Int. J. Nanomed., 8, 3255
- Yuan F., 1995, Cancer Res., 55, 3752
- Jain R. K., 1987, Cancer Res., 47, 3039
- 10.1021/nn900002m · DOI · Paper page
- Chidambaram M., 2012, Int. J. Pharm. Sci., 2, 117
- 10.1039/C1CS15237H · DOI · Paper page
- 10.1038/nnano.2007.223 · DOI · Paper page
- Mohanraj V. J., 2006, Trop. J. Pharm. Res., 5, 561
- Hong R. L., 1999, Clin. Cancer Res., 5, 3645
- Shamsipour F., 2009, Avicenna J. Med. Biotechnol., 1, 27
- Park J. W., 2002, Clin. Cancer Res., 8, 1172
- Uppada S. B., 2014, Int. J. Nanomed., 9, 43
- Bangham A. D., 1965, J. Mol. Biol., 13, 227
- Mueller C., 1994, Methods Cell Sci., 16, 183
- 10.1016/j.cbpa.2005.10.005 · DOI
Cited by
Items 301–400 of 1,005
Functional Enzyme Mimics for Oxidative Halogenation Reactions that Combat Biofilm Formation
Herget, K., Frerichs, H., Pfitzner, F., Tahir, M. N., & Tremel, W. (2018) · Advanced Materials · doi:10.1002/adma.201707073 · Cited by 99
Package delivered: folate receptor-mediated transporters in cancer therapy and diagnosis
Ahmadi, M., Ritter, C. A., von Woedtke, T., Bekeschus, S., & Wende, K. (2024) · Chemical Science · doi:10.1039/d3sc05539f · Cited by 114
Xiong, H., Zhou, D., Qi, Y., Zhang, Z., Xie, Z., Chen, X., Jing, X., Meng, F., & Huang, Y. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b01311 · Cited by 97
Polymer Nanocontainers for Intracellular Delivery
Chali, S. P., & Ravoo, B. J. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201907484 · Cited by 97
Multifunctional silica nanoparticles as a promising theranostic platform for biomedical applications
Xu, Z., Ma, X., Gao, Y.-E., Hou, M., Xue, P., Li, C. M., & Kang, Y. (2017) · Materials Chemistry Frontiers · doi:10.1039/c7qm00153c · Cited by 99
Mukherjee, S., Kotcherlakota, R., Haque, S., Bhattacharya, D., Kumar, J. M., Chakravarty, S., & Patra, C. R. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110375 · Cited by 98
Targeting Engineered Nanoparticles for Breast Cancer Therapy
Ganesan, K., Wang, Y., Gao, F., Liu, Q., Zhang, C., Li, P., Zhang, J., & Chen, J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111829 · Cited by 108
Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment
Yu, S., Wang, Y., He, P., Shao, B., Liu, F., Xiang, Z., Yang, T., Zeng, Y., He, T., Ma, J., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.809304 · Cited by 115
“Nanomaterials are expected to overcome the limitations of traditional drug delivery systems, including low water solubility, low bioavailability, multidrug resistance, and non-specificity (114, 115).”
BackgroundUltrasmall Enzyme-Powered Janus Nanomotor Working in Blood Circulation System
Yang, Z., Wang, L., Gao, Z., Hao, X., Luo, M., Yu, Z., & Guan, J. (2023) · ACS Nano · doi:10.1021/acsnano.3c00548 · Cited by 96
Carbon Nanomaterials for Biomedical Applications: Progress and Outlook
Malode, S. J., Pandiaraj, S., Alodhayb, A. N., & Shetti, N. P. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00983 · Cited by 98
Ghanbari-Movahed, M., Mondal, A., Farzaei, M. H., & Bishayee, A. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153909 · Cited by 103
Near-Infrared Laser-Driven in Situ Self-Assembly as a General Strategy for Deep Tumor Therapy
Liu, F., Cong, Y., Qi, G., Ji, L., Qiao, Z., & Wang, H. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b03174 · Cited by 94
Mass spectrometry imaging of the in situ drug release from nanocarriers
Xue, J., Liu, H., Chen, S., Xiong, C., Zhan, L., Sun, J., & Nie, Z. (2018) · Science Advances · doi:10.1126/sciadv.aat9039 · Cited by 93
“The nanoscale drug carriers have the potential to protect small molecular anticancer drugs from rapid clearance in the bloodstream (3, 4), overcome the physiological barriers (5), and accumulate specifically in the tumor areas (6).”
BackgroundComprehensive Insights into Medicinal Research on Imidazole-Based Supramolecular Complexes
Li, S.-R., Tan, Y.-M., Zhang, L., & Zhou, C. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051348 · Cited by 104
Emerging integrated nanoclay-facilitated drug delivery system for papillary thyroid cancer therapy
Zhang, Y., Long, M., Huang, P. F., Yang, H., Chang, S., Hu, Y., Tang, A., & Mao, L. (2016) · Scientific Reports · doi:10.1038/srep33335 · Cited by 107
Self-citationWu, M., Wang, Y., Wang, Y., Zhang, M., Luo, Y., Tang, J., Wang, Z., Wang, D., Hao, L., & Wang, Z. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s136032 · Cited by 96
Gold nanocages for effective photothermal conversion and related applications
Qiu, J., Xie, M., Wu, T. S., Qin, D., & Younan Xia, A. (2020) · Chemical Science · doi:10.1039/d0sc05146b · Cited by 93
Near-infrared light-triggered nano-prodrug for cancer gas therapy
Liu, R., Peng, Y., Lu, L., Peng, S., Chen, T., & Zhan, M. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01078-x · Cited by 97
“concentration at the tumor site, reducing the therapeutic effects [137].”
BackgroundSynthetic methods of CuS nanoparticles and their applications for imaging and cancer therapy
Wang, L. (2016) · RSC Advances · doi:10.1039/c6ra18355g · Cited by 98
Mesoporous Silica Materials as Drug Delivery: “The Nightmare” of Bacterial Infection
Martínez‐Carmona, M., Gun’ko, Y. K., & Vallet‐Regí, M. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040279 · Cited by 100
“In cancer, the enhanced permeability and retention effect (EPR), also called “passive targeting” is very common [81].”
BackgroundYuan, H., Nai, J., Fang, Y., Lu, G., Tao, X., & Lou, X. W. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202001989 · Cited by 92
Nano-immunotherapy: Unique mechanisms of nanomaterials in synergizing cancer immunotherapy
Liu, Q., Duo, Y., Fu, J., Qiu, M., Sun, Z., Adah, D., Kang, J., Xie, Z., Fan, T., Bao, S., et al. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101023 · Cited by 97
Munir, I., Perveen, M., Nazir, S., Khera, R. A., Ayub, A. R., Ayub, K., & Javed Iqbal, M. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.116327 · Cited by 92
Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers
Kesharwani, P., Halwai, K., Jha, S. K., Mughram, M. H. A., Almujri, S. S., Almalki, W. H., & Sahebkar, A. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02163-z · Cited by 109
Ma, Y., Wang, Z., Ma, Y., Han, Z., Zhang, M., Chen, H., & Gu, Y. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201801195 · Cited by 93
Yan, C., Guo, Z., Shen, Y., Chen, Y., Tian, H., & Zhu, W. (2018) · Chemical Science · doi:10.1039/c8sc01069b · Cited by 91
Phua, S. Z. F., Xue, C., Lim, W. Q., Yang, G., Chen, H., Zhang, Y., Wijaya, C. F., Luo, Z. Y., & Zhao, Y. (2019) · Chemistry of Materials · doi:10.1021/acs.chemmater.9b00439 · Cited by 102
Self-citationZhang, J., Liu, K., Müllen, K., & Yin, M. (2015) · Chemical Communications · doi:10.1039/c5cc03016a · Cited by 95
Ghosh, A., Xu, W., Gupta, N., & Gracias, D. H. (2020) · Nano Today · doi:10.1016/j.nantod.2019.100836 · Cited by 101
Mesenchymal stem cells: A living carrier for active tumor-targeted delivery
Zhang, T., Lin, R., Wu, H., Jiang, X., & Gao, J. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114300 · Cited by 95
Zebrafish as a model system for characterization of nanoparticles against cancer
Evensen, L., Johansen, P. L., Koster, G., Zhu, K., Herfindal, L., Speth, M. T., Fenaroli, F., Hildahl, J., Bagherifam, S., Tulotta, C., et al. (2015) · Nanoscale · doi:10.1039/c5nr07289a · Cited by 100
Synthesis and Evaluation of Paclitaxel-Loaded Gold Nanoparticles for Tumor-Targeted Drug Delivery
Paciotti, G. F., Zhao, J., Cao, S., Brodie, P. J., Tamarkin, L., Huhta, M. S., Myer, L. D., Friedman, J., & Kingston, D. G. I. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00405 · Cited by 93
Self‐Assembled Nanoparticles from Phenolic Derivatives for Cancer Therapy
Dai, Y., Guo, J., Wang, T., Ju, Y., Mitchell, A. J., Bonnard, T., Cui, J., Richardson, J. J., Hagemeyer, C. E., Alt, K., et al. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700467 · Cited by 90
Kou, L., Yao, Q., Sivaprakasam, S., Luo, Q., Sun, Y. H., Fu, Q., He, Z., Sun, J., & Ganapathy, V. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1377316 · Cited by 92
“Over the past few decades, significant progress has been made in the application of nanoparticles (liposomes, polymeric nanoparticles, micelles, dendrimers, etc.) for drug delivery (Couvreur, 2013; Sun et al., 2015).”
BackgroundXu, Z., Liu, S., Kang, Y., & Wang, M. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00119 · Cited by 91
Intravitreal nanoparticles for retinal delivery
Huang, X., & Chau, Y. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.05.005 · Cited by 86
Hybrid Biodegradable Nanomotors through Compartmentalized Synthesis
Pijpers, I. A. B., Cao, S., Llopis‐Lorente, A., Zhu, J., Song, S., Joosten, R. R. M., Meng, F., Friedrich, H., Williams, D. S., Sánchez, S., et al. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c01268 · Cited by 90
Tortella, G., Pieretti, J. C., Rubilar, O., Fernández‐Baldo, M. A., Benavides‐Mendoza, A., Diez, M. C., & Seabra, A. B. (2021) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2021.1939260 · Cited by 97
“, have allowed enhanced activity with minimal unwanted side effects [52].”
BackgroundCurrent trends and future perspectives of nanomedicine for the management of colon cancer
Wahab, S., Alshahrani, M. Y., Ahmad, M. F., & Abbas, H. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174464 · Cited by 96
Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy
Dubey, A. K., & Mostafavi, E. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1259435 · Cited by 103
“Viral shape and functionality can be mimicked by protein-based nanoparticles, such as virus-like particles (VLPs), which are made of proteins (Sun et al., 2014; Bulbake et al., 2017; Nsairat et al., 2022).”
BackgroundSwitchable Lipids: Conformational Change for Fast pH‐Triggered Cytoplasmic Delivery
Viricel, W., Mbarek, A., & Chain, J. L. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201504661 · Cited by 100
Single and Multiple Stimuli-Responsive Polymer Particles for Controlled Drug Delivery
Ruiz, A. L., Ramirez, A., & McEnnis, K. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020421 · Cited by 104
BHANGE, M. A., & Telange, D. R. (2025) · Discover Oncology · doi:10.1007/s12672-025-01821-y · Cited by 123
Cancer Diagnosis and Imaging-Guided Photothermal Therapy Using a Dual-Modality Nanoparticle
Zeng, C., Shang, W., Liang, X., Liang, X. Y., Chen, Q., Chi, C., Du, Y., Fang, C., & Tian, J. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b06883 · Cited by 86
Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy
Huang, M., Zhai, B., Fan, Y. B., Sun, J., Shi, Y., Zhang, X., Zou, J., Wang, J., & Guo, D. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s410688 · Cited by 95
“John Wiley and Sons.(88) © 2014 WILEY-VCH Verlag GmbH & Co.”
BackgroundNanoparticle-mediated thermal Cancer therapies: Strategies to improve clinical translatability
Bravo, M., Fortuni, B., Mulvaney, P. A., Hofkens, J., Uji‐i, H., Rocha, S., & Hutchison, J. A. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.06.055 · Cited by 99
Lignos, I. G., Stavrakis, S., Kilaj, A., & deMello, A. J. (2015) · Small · doi:10.1002/smll.201500119 · Cited by 86
Lim, W. Q., Phua, S. Z. F., Xu, H. V., Sreejith, S., & Zhao, Y. (2015) · Nanoscale · doi:10.1039/c5nr07853a · Cited by 87
Microgels in biomaterials and nanomedicines
Wang, Y., Guo, L., Dong, S., Cui, J., & Hao, J. (2019) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2019.01.005 · Cited by 93
Nano-Medicine for Thrombosis: A Precise Diagnosis and Treatment Strategy
Su, M., Dai, Q., Chen, C., Zeng, Y., Chu, C., & Liu, G. (2020) · Nano-Micro Letters · doi:10.1007/s40820-020-00434-0 · Cited by 85
Kankala, R. K., Xu, P., Chen, B., Wang, S., & Chen, A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113846 · Cited by 87
Immunomodulatory effect of mushrooms and their bioactive compounds in cancer: A comprehensive review
Pathak, M. P., Pathak, K., Saikia, R., Gogoi, U., Ahmad, M. Z., Patowary, P., & Das, A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112901 · Cited by 96
Yang, H., Shen, W. H., Liu, W., Chen, L., Zhang, P., Xiao, C., & Chen, X. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b01394 · Cited by 85
Black phosphorus: A novel nanoplatform with potential in the field of bio-photonic nanomedicine
Fan, T., Zhou, Y., Qiu, M., & Zhang, H. (2018) · Journal of Innovative Optical Health Sciences · doi:10.1142/s1793545818300033 · Cited by 84
Li, Y., Yang, Y., Chen, H., Mei, L., & Zeng, X. (2021) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2021.07.002 · Cited by 92
Putting Gold Nanocages to Work For Optical Imaging, Controlled Release and Cancer Theranostics
Pang, B., Yang, X., & Younan Xia, A. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0109 · Cited by 83
Self-citationDebnath, G., Das, P., & Saha, A. K. (2019) · BioNanoScience · doi:10.1007/s12668-019-00650-y · Cited by 83
“Nanoscience deals with the synthesis of little particles termed nanoparticles (< 100 nm in size), which may supply as building blocks in a variety of natural systems [1].”
Applications of Two-Dimensional Nanomaterials in Breast Cancer Theranostics
Mohammadpour, Z., & Majidzadeh‐A, K. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01894 · Cited by 84
Guo, Y. L., Wang, M., Zou, Y., Jin, L., Zhao, Z., Liu, Q., Wang, S., & Li, J. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01586-4 · Cited by 94
“Due to the EPR effect, nano-drugs with diameters between 10 and 100 nm are enriched in tumor tissues, forming a passive targeting of nano-drugs to tumor tissues [132].”
BackgroundBiomimetic cell-derived nanocarriers in cancer research
Soprano, E., Polo, E., Pelaz, B., & del Pino, P. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01748-4 · Cited by 91
“Furthermore, their modifiable structure offers the possibility of encapsulating the drug or conjugating it on the surface, by adsorption or chemical bond, thus protecting it from premature degradation and/or elimination in vivo and, at the same time, guaranteeing its solubility in the biological environment [2].”
BackgroundPeptide-modulated self-assembly as a versatile strategy for tumor supramolecular nanotheranostics
Li, S., Zou, Q., Xing, R., Govindaraju, T., Fakhrullin, R., & Yan, X. (2019) · Theranostics · doi:10.7150/thno.31814 · Cited by 83
“Nanotechnology, exploited as emerging techniques for the fabrication of nanomaterials, has produced a large arsenal of nanomaterials with diversified capabilities in diagnosis and therapy [7-11].”
BackgroundEffects of hypoxia and nanocarrier size on pH-responsive nano-delivery system to solid tumors
Soltani, M., Souri, M., & Moradi Kashkooli, F. (2021) · Scientific Reports · doi:10.1038/s41598-021-98638-w · Cited by 82
Chen, W., Zou, Y., Zhong, Z., & Haag, R. (2016) · Small · doi:10.1002/smll.201601997 · Cited by 82
Bajpai, V. K., Shukla, S., Kang, S., Hwang, S. K., Song, X., Huh, Y. S., & Han, Y. (2018) · Marine Drugs · doi:10.3390/md16060179 · Cited by 86
“Many natural compound-based drugs against cancer have been discovered, but they have poor water solubility, which makes their formulation difficult or even impossible [11].”
BackgroundWang, W., Wang, P., Chen, L., Zhao, M., Hung, C., Yu, C., Al-Khalaf, A. A., Hozzein, W. N., Zhang, F., Li, X., et al. (2020) · Chem · doi:10.1016/j.chempr.2020.01.010 · Cited by 82
Incorporation of Ru(II) Polypyridyl Complexes into Nanomaterials for Cancer Therapy and Diagnosis
Soliman, N., Gasser, G., & Thomas, C. M. (2020) · Advanced Materials · doi:10.1002/adma.202003294 · Cited by 82
Zhang, T., Huang, P., Shi, L., Su, Y., Zhou, L., Zhu, X., & Yan, D. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00005 · Cited by 81
Biomedical applications of metal organic polygons and polyhedra (MOPs)
Samanta, S. K., & Isaacs, L. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213181 · Cited by 83
Ellis, E., Zhang, K., Lin, Q., Ye, E., Poma, A., Battaglia, G., Loh, X. J., & Lee, T. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb00654c · Cited by 83
Synthetic Approaches for Nucleic Acid Delivery: Choosing the Right Carriers
Ni, R., Feng, R., & Chau, Y. (2019) · Life · doi:10.3390/life9030059 · Cited by 92
Polypeptides–Drug Conjugates for Anticancer Therapy
Zhang, Y. X., He, P., Zhang, P., Yi, X., Xiao, C., & Chen, X. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001974 · Cited by 80
Self-citationHuang, C., Chuang, C.-P., Chen, Y., Wang, H.-Y., Lin, J., Huang, C.-Y., Wei, K., & Huang, F. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00925-1 · Cited by 87
Green-synthesized metal nanoparticles: a promising approach for accelerated wound healing
Singaravelu, S., Motsoene, F., Abrahamse, H., & Kumar, S. S. D. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1637589 · Cited by 106
“Gold nanoparticles (AuNPs) are renowned for their unique optical properties, facile synthesis, and exceptional chemical stability, making them highly advantageous for applications in cancer therapy, bioimaging, biosensing, and targeted drug delivery (Sun et al., 2021).”
Improving proton therapy by metal-containing nanoparticles: nanoscale insights
Schlathölter, T., Lacombe, S., Eustache, P., Porcel, E., Leza, D. S., Štefančíková, L., Tillement, O., Lux, F., Mowat, P., van Goethem, M., et al. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s99410 · Cited by 86
Cyclodextrin-Based Magnetic Nanoparticles for Cancer Therapy
Mrówczyński, R., Jędrzak, A., Szutkowski, K., Grześkowiak, B. F., Coy, E. L., Markiewicz, R., Jesionowski, T., & Jurga, S. (2018) · Nanomaterials · doi:10.3390/nano8030170 · Cited by 81
Huang, C., Tan, W., Zheng, J., Zhu, C., Huo, J., & Yang, R. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b08115 · Cited by 82
Khodashenas, B., Ardjmand, M., Rad, A. S., & Esfahani, M. R. (2021) · Materials Today Chemistry · doi:10.1016/j.mtchem.2021.100474 · Cited by 79
Biomimetic Exosomes: A New Generation of Drug Delivery System
Wang, X., Zhao, X., Zhong, Y., Shen, J., & An, W. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.865682 · Cited by 105
Lysosomal-mediated drug release and activation for cancer therapy and immunotherapy
Sun, Y., Sha, Y., Cui, G., Meng, F., & Zhong, Z. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114624 · Cited by 83
Chakraborty, I., Carrington, S. J., Hauser, J. L., Oliver, S. R. J., & Mascharak, P. K. (2015) · Chemistry of Materials · doi:10.1021/acs.chemmater.5b03859 · Cited by 78
Rod-shaped mesoporous silica nanoparticles for nanomedicine: recent progress and perspectives
Cong, V. T., Gaus, K., Tilley, R. D., & Gooding, J. J. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1517748 · Cited by 80
Magnetic/pH-sensitive double-layer microrobots for drug delivery and sustained release
Chen, W., Sun, M., Fan, X., & Xie, H. (2020) · Applied Materials Today · doi:10.1016/j.apmt.2020.100583 · Cited by 83
Smart nanocarriers for cancer treatment: Clinical impact and safety
Liao, Z., Wong, S. W., Yeo, H. L., & Zhao, Y. (2020) · NanoImpact · doi:10.1016/j.impact.2020.100253 · Cited by 88
Gurnani, P., Sánchez-Cano, C., Xandri‐Monje, H., Zhang, J., Ellacott, S. H., Mansfield, E. D. H., Hartlieb, M., Dallmann, R., & Perrier, S. (2022) · Small · doi:10.1002/smll.202203070 · Cited by 86
Dual-drug codelivery nanosystems: An emerging approach for overcoming cancer multidrug resistance
Gong, J., Shi, T., Liu, J., Pei, Z., Liu, J., Ren, X., Li, F., & Qiu, F. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114505 · Cited by 86
Yu, M., Xue, Y., Ma, P. X., Mao, C., & Lei, B. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b13874 · Cited by 81
Fresta, C. G., Chakraborty, A., Wijesinghe, M. B., Amorini, A. M., Lazzarino, G., Lazzarino, G., Tavazzi, B., Lunte, S. M., Caraci, F., Dhar, P., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0280-z · Cited by 85
Mei, K., Bai, J., Lorrio, S., Wang, J. T.-W., & Al‐Jamal, K. T. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.030 · Cited by 79
“Cancer therapy, therefore, is often terminated as a result of the severe side effects, caused by the therapeutic agents, before the expected therapeutic outcome is reached [1].”
BackgroundRedox-triggered activation of nanocarriers for mitochondria-targeting cancer chemotherapy
Zhou, W., Yu, H. M., Zhang, L.-J., Wu, B., Wang, C., Wang, Q., Deng, K., Zhuo, R., & Huang, S. (2017) · Nanoscale · doi:10.1039/c7nr06130g · Cited by 82
Modular Hepatitis B Virus-like Particle Platform for Biosensing and Drug Delivery
Hartzell, E. J., Lieser, R. M., Sullivan, M. O., & Chen, W. (2020) · ACS Nano · doi:10.1021/acsnano.9b08756 · Cited by 81
Huang, Y., Zhang, G., Hu, F., Jin, Y., Zhao, R., & Zhang, D. (2016) · Chemical Science · doi:10.1039/c6sc02395a · Cited by 79
A Sweet Polydopamine Nanoplatform for Synergistic Combination of Targeted Chemo-Photothermal Therapy
Gao, Y., Wu, X., Zhou, L., Su, Y., & Dong, C. (2015) · Macromolecular Rapid Communications · doi:10.1002/marc.201500090 · Cited by 78
Wu, L., Lin, B., Huang, Y., Chen, J., Mao, Z., Wang, W., & Gao, C. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.01.026 · Cited by 76
Superparamagnetic iron-doped nanocrystalline apatite as a delivery system for doxorubicin
Iafisco, M., Drouet, C., Adamiano, A., Pascaud, P., Montesi, M., Panseri, S., Sarda, S., & Tampieri, A. (2016) · Journal of Materials Chemistry B · doi:10.1039/c5tb01524c · Cited by 76
Advancing Tissue Engineering: A Tale of Nano‐, Micro‐, and Macroscale Integration
Leijten, J., Rouwkema, J., Zhang, Y. S., Nasajpour, A., Dokmeci, M. R., & Khademhosseini, A. (2016) · Small · doi:10.1002/smll.201501798 · Cited by 76
Self-citationHussain, M., Raja, N. I., Mashwani, Z., Iqbal, M., Sabir, S., & Yasmeen, F. (2017) · 3 Biotech · doi:10.1007/s13205-017-0741-6 · Cited by 78
“Nanoparticles have dimension between 1 and 100 nm that serve as a building block for various physical and biological systems (Sun et al. 2014).”
BackgroundLim, W. Q., Yang, G., Phua, S. Z. F., Chen, H., & Zhao, Y. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b04557 · Cited by 77
Smart H2S‐Triggered/Therapeutic System (SHTS)‐Based Nanomedicine
Chen, W., Ni, D., Rosenkrans, Z. T., Cao, T., & Cai, W. (2019) · Advanced Science · doi:10.1002/advs.201901724 · Cited by 81
Bringing Again Noble Metal Nanoparticles to the Forefront of Cancer Therapy
Vlamidis, Y., & Voliani, V. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00143 · Cited by 77
Lai, Y., Chiang, C.-S., Hsu, C.-H., Cheng, H., & Chen, S. (2020) · Biomolecules · doi:10.3390/biom10070970 · Cited by 79
“Cancer is one of the leading causes of death worldwide, and a major reason for the limited therapeutic efficacy against cancer is the difficulty to deliver therapeutic agents precisely and effectively to the tumor sites without inducing severe adverse effects on healthy tissues and organs [1,2].”
Background
Metadata
- Authors
- Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y.
- Affiliations
- Georgia Institute of Technology (US)
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2014-10-07
- Volume
- 53
- Issue
- 46
- Pages
- 12320-12364
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2134726513
- Cited by
- 2,164
- References
- 578
- Citations by year
- 2026: 57 · 2025: 146 · 2024: 163 · 2023: 153 · 2022: 209 · 2021: 200 · 2020: 221 · 2019: 237 · 2018: 257 · 2017: 230 · 2016: 180 · 2015: 109 · 2014: 2
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Angewandte Chemie International Edition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- engineered nanoparticles, drug delivery, cancer therapy, targeted drug delivery, enhanced permeability and retention effect, pH-responsive delivery, tumor-targeting ligands, tissue distribution, circulation half-life, immunogenicity, combination therapy, multidrug resistance, contrast media, theranostics, nanoparticle surface modification
- MeSH terms
- Animals, Antineoplastic Agents, Delayed-Action Preparations, Humans, Neoplasms, Drug Delivery Systems, Nanotechnology, Nanomedicine, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.